Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06984055

Diagnostic Accuracy of Endocytoscopy for Superficial Esophageal Neoplasia

Diagnostic Accuracy of Deep Learning-Assisted Multimodal Endocytoscopy for Superficial Esophageal Neoplasia and Precancerous Lesions: A Multicenter ,Prospective Study

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
600 (estimated)
Sponsor
Changhai Hospital · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

In recent years, endocytoscopy (EC) has undergone rapid development as an advanced endoscopic technique. Characterized by real-time histological imaging and detection capabilities, EC enables visualization of living cells in the digestive mucosal layer through methylene blue staining via the endoscopic instrument channel. This technology provides ultra-magnified endocytoscopic images, allowing for identification of key cellular features including epithelial cell morphology and the shape of methylene blue-stained epithelial nuclei, thereby facilitating clear in vivo observation of microstructural characteristics in mucosal tissues - a technique commonly referred to as "optical biopsy". However, current clinical application of EC in China remains limited due to insufficient practical experience and the absence of standardized diagnostic criteria for image interpretation. This study aims to comprehensively evaluate the diagnostic accuracy of domestically developed high-magnification electronic upper gastrointestinal endoscopy for esophageal carcinoma and precancerous lesions, using histopathology as the gold standard. The research objectives include establishing standardized diagnostic evaluation protocols and clarifying the clinical value of this technology through systematic validation.

Conditions

Timeline

Start date
2025-03-11
Primary completion
2026-12-01
Completion
2026-12-01
First posted
2025-05-22
Last updated
2025-05-22

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06984055. Inclusion in this directory is not an endorsement.